Join date: Aug 6, 2020
Jun 7, 2022 ∙ 2 min
Basilea - The prospects for anti-infectives
Basilea faces an important data read out in the next few months that could significantly enhance its anti-infectives franchise. Our...
Apr 1, 2022 ∙ 2 min
Diurnal Group - SMC decision, financial results and outlook
We published a research report today following Diurnal's recent results and the SMC's decision not to automatically reimburse Efmody....